Aldosterone synthase inhibitors
US9334285B2 · kind B2 · utility
4Cited by
0References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2015 |
| Grant date | May 10, 2016 |
| Priority date | — |
| Expiry date | Jul 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I:and pharmaceutically acceptable salts thereof, wherein Cy, R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.